2,011 results on '"El-Serag, Hashem"'
Search Results
2. Emergency Presentations Predict Worse Outcomes Among Patients with Pancreatic Cancer
3. PNPLA3, Obesity, and Heavy Alcohol Use in Cirrhosis Patients May Exert a Synergistic Increase Hepatocellular Carcinoma Risk
4. Diabetes Status and Pancreatic Cancer Survival in the Nationwide Veterans Affairs Healthcare System
5. Gastric Cancer Risk in Patients with Long-Term Use of Proton Pump Inhibitors: A Systematic Review and Meta-Analysis of Observational and Interventional Studies
6. Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment
7. Hepatocellular and extrahepatic cancer risk in people with non-alcoholic fatty liver disease
8. Evolving Concepts in Helicobacter pylori Management
9. Defining and Understanding Diagnostic Delays Among Pancreatic Cancer Patients: A Retrospective Cohort Study
10. Race/ethnicity and sex differences in the association between area-level arsenic exposure concentration and hepatocellular carcinoma (HCC) incidence rates in Texas. An ecological study
11. Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention
12. Clinical Course and Outcomes of Patients with Nonalcoholic Fatty Liver Disease-Related Hepatocellular Cancer (NAFLD-HCC)
13. Missed Opportunities for Screening or Surveillance Among Patients with Newly Diagnosed Non-cardia Gastric Adenocarcinoma
14. Risk Stratification Model for Hepatocellular Cancer in Patients With Cirrhosis
15. Validation of a pre-endoscopy risk score for predicting the presence of gastric intestinal metaplasia in a U.S. population
16. Risk of Hepatocellular Carcinoma in Patients with Various HFE Genotypes
17. Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy
18. Prevention of Hepatocellular Carcinoma (HCC). White Paper of the Texas Collaborative Center for Hepatocellular Cancer (TeCH) Multi-stakeholder Conference
19. Development and Validation of the Houston-BEST, a Barrett’s Esophagus Risk Prediction Model Adaptable to Electronic Health Records
20. Recent Decline in the Incidence of Hepatocellular Carcinoma in the United States
21. Contemporary Changes in Etiology for Hepatocellular Carcinoma in Liver Transplantation
22. The Predictive Performance of Contemporary Guideline Recommendations for Helicobacter pylori Testing in a United States Population
23. Using Natural Language Processing to Automatically Identify Dysplasia in Pathology Reports for Patients With Barrett’s Esophagus
24. Neighborhood-Level Factors Contribute to Disparities in Hepatocellular Carcinoma Incidence in Texas
25. The Prevalence and Determinants of NAFLD and MAFLD and Their Severity in the VA Primary Care Setting
26. Admixture Mapping in African Americans Identifies New Risk Loci for HCV-Related Cirrhosis
27. The Risk of Hepatocellular Carcinoma in Entecavir Versus Tenofovir Treated US Cohort With Chronic Hepatitis B Virus
28. Longitudinal changes in fibrosis markers are associated with risk of cirrhosis and hepatocellular carcinoma in non-alcoholic fatty liver disease
29. Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight
30. Risk Score Using Demographic and Clinical Risk Factors Predicts Gastric Intestinal Metaplasia Risk in a U.S. Population
31. The Performance of AFP, AFP-3, DCP as Biomarkers for Detection of Hepatocellular Carcinoma (HCC): A Phase 3 Biomarker Study in the United States
32. Inverse Association Between Gluteofemoral Obesity and Risk of Non-Cardia Gastric Intestinal Metaplasia
33. Endoscopic Ultrasound Finding of Diffuse Echogenicity in the Pancreas, Is It Relevant?
34. Comparative Effectiveness of Surveillance Colonoscopy Intervals on Colorectal Cancer Outcomes in a National Cohort of Patients with Inflammatory Bowel Disease
35. Risk for Post-Colonoscopy Irritable Bowel Syndrome in Patients With and Without Antibiotic Exposure: A Retrospective Cohort Study
36. Spatial Characteristics of Colonic Mucosa-Associated Gut Microbiota in Humans
37. Perceptions of weight status and energy balance behaviors among patients with non-alcoholic fatty liver disease
38. A Conceptual Model for Implementation and Evaluation of Interventions Across the Hepatocellular Carcinoma Care Continuum
39. Prevalence and Predictors of Missed Dysplasia on Index Barrett’s Esophagus Diagnosing Endoscopy in a Veteran Population
40. GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.
41. The road to a world-unified approach to the management of patients with gastric intestinal metaplasia: a review of current guidelines.
42. Contemporary epidemiology of hepatocellular carcinoma: understanding risk factors and surveillance strategies.
43. Differences in Prediagnostic Serum Metabolomic and Lipidomic Profiles Between Cirrhosis Patients with and without Incident Hepatocellular Carcinoma.
44. Physician Reimbursement for Endoscopic Submucosal Dissection: A Single Center Analysis
45. Functional Dyspepsia and Duodenal Eosinophil Count and Degranulation: A Multiethnic US Veteran Cohort Study
46. Oral Health and the Altered Colonic Mucosa-Associated Gut Microbiota
47. Factors Associated With Delay of Diagnosis of Hepatocellular Carcinoma in Patients With Cirrhosis
48. Validation of the Updated Hepatocellular Carcinoma Early Detection Screening Algorithm in a Community-Based Cohort of Patients With Cirrhosis of Multiple Etiologies
49. Burden of Pancreatic Cancer: From Epidemiology to Practice
50. External Validation of Four Point-of-Care Noninvasive Scores for Predicting Advanced Hepatic Fibrosis in a Predominantly Hispanic NAFLD Population
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.